Intellia Therapeutics Inc buy Stifel Nicolaus
Start price
11.09.24
/
50%
€18.23
Target price
11.09.25
€58.07
Performance (%)
-46.91%
End price
12.09.25
€9.68
Summary
This prediction ended on 12.09.25 with a price of €9.68. The BUY prediction by Stifel_Nicolaus for Intellia Therapeutics Inc performed very badly with a performance of -46.91%. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -2.653% | -2.653% | 77.502% |
| iShares Core DAX® | -1.862% | 0.670% | 0.920% |
| iShares Nasdaq 100 | -3.322% | 4.989% | 33.716% |
| iShares Nikkei 225® | -2.299% | 6.129% | 52.955% |
| iShares S&P 500 | -1.313% | 3.399% | 24.674% |
Comments by Stifel_Nicolaus for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Stifel Nicolaus from $80.00 to $64.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten